201 related articles for article (PubMed ID: 24218026)
1. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
[TBL] [Abstract][Full Text] [Related]
2. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'.
Uner A; Akyurek N; Saglam A; Abdullazade S; Uzum N; Onder S; Barista I; Benekli M
APMIS; 2011 Apr; 119(4-5):309-16. PubMed ID: 21492232
[TBL] [Abstract][Full Text] [Related]
3. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
Gualco G; Weiss LM; Barber GN; Bacchi CE
Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
[TBL] [Abstract][Full Text] [Related]
4. Diffuse large B-cell lymphoma involving the central nervous system.
Gualco G; Weiss LM; Barber GN; Bacchi CE
Int J Surg Pathol; 2011 Feb; 19(1):44-50. PubMed ID: 21087986
[TBL] [Abstract][Full Text] [Related]
5. Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group.
Yamauchi A; Fujita S; Ikeda J; Nakamichi I; Fukuhara S; Hino M; Kanakura Y; Ogawa H; Sugiyama H; Kanamaru A; Aozasa K
Am J Hematol; 2007 Oct; 82(10):893-7. PubMed ID: 17573693
[TBL] [Abstract][Full Text] [Related]
6. The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
Bavi P; Uddin S; Bu R; Ahmed M; Abubaker J; Balde V; Qadri Z; Ajarim D; Al-Dayel F; Hussain AR; Al-Kuraya KS
J Pathol; 2011 Jul; 224(3):355-66. PubMed ID: 21506127
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma in the spinal epidural space: A study of the Osaka Lymphoma Study Group.
Wada N; Kohara M; Ikeda J; Hori Y; Fujita S; Okada M; Ogawa H; Sugiyama H; Fukuhara S; Kanamaru A; Hino M; Kanakura Y; Morii E; Aozasa K
Pathol Res Pract; 2010 Jul; 206(7):439-44. PubMed ID: 20399024
[TBL] [Abstract][Full Text] [Related]
8. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
[TBL] [Abstract][Full Text] [Related]
10. Primary tonsillar lymphomas according to the new World Health Organization classification: to report 87 cases and literature review and analysis.
Mohammadianpanah M; Daneshbod Y; Ramzi M; Hamidizadeh N; Dehghani SJ; Bidouei F; Khademi B; Ahmadloo N; Ansari M; Omidvari S; Mosalaei A; Dehghani M
Ann Hematol; 2010 Oct; 89(10):993-1001. PubMed ID: 20440503
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.
Hoeller S; Tzankov A; Pileri SA; Went P; Dirnhofer S
Hum Pathol; 2010 Mar; 41(3):352-7. PubMed ID: 19913281
[TBL] [Abstract][Full Text] [Related]
12. Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.
Castillo JJ; Beltran BE; Miranda RN; Paydas S; Winer ES; Butera JN
Oncologist; 2011; 16(1):87-96. PubMed ID: 21212426
[TBL] [Abstract][Full Text] [Related]
13. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma.
Park S; Lee J; Ko YH; Han A; Jun HJ; Lee SC; Hwang IG; Park YH; Ahn JS; Jung CW; Kim K; Ahn YC; Kang WK; Park K; Kim WS
Blood; 2007 Aug; 110(3):972-8. PubMed ID: 17400912
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
15. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
16. Epstein-barr virus in diffuse large B-Cell lymphoma in immunocompetent patients in Japan is as low as in Western Countries.
Wada N; Ikeda J; Hori Y; Fujita S; Ogawa H; Soma T; Sugiyama H; Fukuhara S; Kanamaru A; Hino M; Kanakura Y; Morii E; Aozasa K
J Med Virol; 2011 Feb; 83(2):317-21. PubMed ID: 21181929
[TBL] [Abstract][Full Text] [Related]
17. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
[TBL] [Abstract][Full Text] [Related]
18. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
Johnson LR; Nalesnik MA; Swerdlow SH
Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
[TBL] [Abstract][Full Text] [Related]
19. BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.
Obermann EC; Csato M; Dirnhofer S; Tzankov A
J Clin Pathol; 2009 Oct; 62(10):903-7. PubMed ID: 19783718
[TBL] [Abstract][Full Text] [Related]
20. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
